Mark Swerdlow

2.3k total citations
97 papers, 872 citations indexed

About

Mark Swerdlow is a scholar working on Surgery, Anesthesiology and Pain Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark Swerdlow has authored 97 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 30 papers in Anesthesiology and Pain Medicine and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark Swerdlow's work include Anesthesia and Sedative Agents (23 papers), Anesthesia and Pain Management (20 papers) and Cardiac, Anesthesia and Surgical Outcomes (11 papers). Mark Swerdlow is often cited by papers focused on Anesthesia and Sedative Agents (23 papers), Anesthesia and Pain Management (20 papers) and Cardiac, Anesthesia and Surgical Outcomes (11 papers). Mark Swerdlow collaborates with scholars based in United Kingdom, United States and Germany. Mark Swerdlow's co-authors include Francis F. Foldes, Ephraim S. Siker, Rebecca Lewis, David G. Armstrong, Soumen Chakraborty, Raphael Yaakov, Özgur Güler, Jingtong Huang, Juan Espinoza and David C. Klonoff and has published in prestigious journals such as Science, The Lancet and PLoS ONE.

In The Last Decade

Mark Swerdlow

89 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Swerdlow United Kingdom 15 293 266 211 122 118 97 872
Gordon M. Wyant Canada 18 560 1.9× 335 1.3× 150 0.7× 183 1.5× 172 1.5× 140 1.2k
J. T. Davidson Israel 15 471 1.6× 548 2.1× 323 1.5× 81 0.7× 118 1.0× 46 1.0k
William G. Brose United States 15 335 1.1× 382 1.4× 344 1.6× 112 0.9× 73 0.6× 24 790
Stuart DuPen United States 8 470 1.6× 438 1.6× 304 1.4× 93 0.8× 48 0.4× 10 854
Bertil Löfström Sweden 17 245 0.8× 426 1.6× 143 0.7× 36 0.3× 134 1.1× 56 898
Janet S. Rowan United States 13 180 0.6× 181 0.7× 294 1.4× 234 1.9× 49 0.4× 18 770
A. Cozian France 15 613 2.1× 538 2.0× 136 0.6× 153 1.3× 144 1.2× 34 1.1k
Anders Dejgård Denmark 8 185 0.6× 265 1.0× 574 2.7× 169 1.4× 34 0.3× 13 916
R.P.F. Scott United States 13 749 2.6× 519 2.0× 69 0.3× 153 1.3× 113 1.0× 29 1.1k
M. Rorarius Finland 17 369 1.3× 611 2.3× 118 0.6× 175 1.4× 138 1.2× 44 1.1k

Countries citing papers authored by Mark Swerdlow

Since Specialization
Citations

This map shows the geographic impact of Mark Swerdlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Swerdlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Swerdlow more than expected).

Fields of papers citing papers by Mark Swerdlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Swerdlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Swerdlow. The network helps show where Mark Swerdlow may publish in the future.

Co-authorship network of co-authors of Mark Swerdlow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Swerdlow. A scholar is included among the top collaborators of Mark Swerdlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Swerdlow. Mark Swerdlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swerdlow, Mark, et al.. (2024). Lepromatous Leprosy and Charcot Neuroarthropathy of Insensate Feet: A Case Report. Cureus. 16(5). e61362–e61362.
2.
Swerdlow, Mark, Jessica Lo, & David G. Armstrong. (2023). Reliability of an AI-Powered Application Across Different Mobile Devices for Assessment of Chronic Wounds. Advances in Wound Care. 13(1). 14–21. 3 indexed citations
3.
Swerdlow, Mark, Özgur Güler, Raphael Yaakov, & David G. Armstrong. (2023). Simultaneous Segmentation and Classification of Pressure Injury Image Data Using Mask‐R‐CNN. Computational and Mathematical Methods in Medicine. 2023(1). 3858997–3858997. 19 indexed citations
4.
Huang, Jingtong, David G. Armstrong, Ashley N. Battarbee, et al.. (2022). Artificial Intelligence for Predicting and Diagnosing Complications of Diabetes. Journal of Diabetes Science and Technology. 17(1). 224–238. 29 indexed citations
5.
Baykaner, Tina, Albert J. Rogers, Mark Swerdlow, et al.. (2019). Online webinar training to analyse complex atrial fibrillation maps: A randomized trial. PLoS ONE. 14(7). e0217988–e0217988. 5 indexed citations
6.
Swerdlow, Mark. (1982). Medico-legal aspects of complications following pain relieving blocks. Pain. 13(4). 321–331. 16 indexed citations
7.
Swerdlow, Mark, et al.. (1981). Anticonvulsant drugs used in the treatment of lancinating pain. A comparison. Anaesthesia. 36(12). 1129–1132. 82 indexed citations
8.
Swerdlow, Mark, et al.. (1978). The role of the anaesthetist in chronic pain management. Anaesthesia. 33(3). 250–257. 7 indexed citations
9.
Swerdlow, Mark, et al.. (1971). A trial of CT1341. British Journal of Anaesthesia. 43(11). 1075–1080. 20 indexed citations
10.
Swerdlow, Mark. (1967). 4 years' Pain Clinic experience. Anaesthesia. 22(4). 568–574. 8 indexed citations
11.
Swerdlow, Mark, et al.. (1967). A DOSE-DURATION TRIAL WITH PROPANIDID. British Journal of Anaesthesia. 39(7). 573–577. 4 indexed citations
12.
Swerdlow, Mark. (1965). A TRIAL OF PROPANIDID (FBA.1420): A NEW ULTRASHORT-ACTING ANAESTHETIC. British Journal of Anaesthesia. 37(10). 785–789. 6 indexed citations
13.
Swerdlow, Mark, et al.. (1964). A COMPARISON OF MORPHINE AND PHENAZOCINE IN POSTOPERATIVE PAIN. British Journal of Anaesthesia. 36(12). 782–786. 8 indexed citations
14.
Swerdlow, Mark, et al.. (1960). Anileridine in anæsthesia. Anaesthesia. 15(3). 280–288. 2 indexed citations
15.
Swerdlow, Mark. (1959). The duration of action of levallorphan. Anaesthesia. 14(2). 178–183. 2 indexed citations
16.
Swerdlow, Mark. (1958). Levallorphan. Anaesthesia. 13(3). 318–323. 6 indexed citations
17.
Swerdlow, Mark. (1957). Respiratory effects of anæsthetics. Anaesthesia. 12(1). 42–48. 5 indexed citations
18.
Swerdlow, Mark. (1957). The respiratory effects of pethidine and levallorphan. Anaesthesia. 12(2). 174–181. 12 indexed citations
19.
Swerdlow, Mark. (1956). FURTHER CSF PRESSURE STUDIES. Anaesthesia. 11(2). 149–155. 5 indexed citations
20.
Siker, Ephraim S., Mark Swerdlow, & Francis F. Foldes. (1954). An Earlobe Algesimeter: A Simple Method of Determining Pain Threshold in Man. Science. 120(3111). 273–274. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026